These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 24676600)

  • 1. Temporal trends in liver-directed therapy of patients with intrahepatic cholangiocarcinoma in the United States: a population-based analysis.
    Amini N; Ejaz A; Spolverato G; Kim Y; Herman JM; Pawlik TM
    J Surg Oncol; 2014 Aug; 110(2):163-70. PubMed ID: 24676600
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endoscopic and surgical therapy for intrahepatic cholangiocarcinoma in the united states: a population-based study.
    Shaib YH; Davila JA; Henderson L; McGlynn KA; El-Serag HB
    J Clin Gastroenterol; 2007; 41(10):911-7. PubMed ID: 18090160
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The long-term outcomes after curative resection for mass-forming intrahepatic cholangiocarcinoma associated with hepatitis C viral infection: a multicenter analysis by Osaka Hepatic Surgery Study Group.
    Uenishi T; Nagano H; Marubashi S; Hayashi M; Hirokawa F; Kaibori M; Matsui K; Kubo S
    J Surg Oncol; 2014 Aug; 110(2):176-81. PubMed ID: 24760391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined hepatocellular-cholangiocarcinoma had poor outcomes after hepatectomy regardless of Allen and Lisa class or the predominance of intrahepatic cholangiocarcinoma cells within the tumor.
    Ariizumi S; Kotera Y; Katagiri S; Nakano M; Yamamoto M
    Ann Surg Oncol; 2012 May; 19(5):1628-36. PubMed ID: 22113592
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intra-arterial therapy for advanced intrahepatic cholangiocarcinoma: a multi-institutional analysis.
    Hyder O; Marsh JW; Salem R; Petre EN; Kalva S; Liapi E; Cosgrove D; Neal D; Kamel I; Zhu AX; Sofocleous CT; Geschwind JF; Pawlik TM
    Ann Surg Oncol; 2013 Nov; 20(12):3779-86. PubMed ID: 23846786
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liver-directed therapy for hepatic metastases in patients undergoing pancreaticoduodenectomy: a dual-center analysis.
    De Jong MC; Farnell MB; Sclabas G; Cunningham SC; Cameron JL; Geschwind JF; Wolfgang CL; Herman JM; Edil BH; Choti MA; Schulick RD; Nagorney DM; Pawlik TM
    Ann Surg; 2010 Jul; 252(1):142-8. PubMed ID: 20531007
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Consideration of the role of radiotherapy for unresectable intrahepatic cholangiocarcinoma: a retrospective analysis of 75 patients.
    Zeng ZC; Tang ZY; Fan J; Zhou J; Qin LX; Ye SL; Sun HC; Wang BL; Li D; Wang JH; Zeng MS; Guo W; Tan YS
    Cancer J; 2006; 12(2):113-22. PubMed ID: 16630402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transplantation versus resection for patients with combined hepatocellular carcinoma-cholangiocarcinoma.
    Groeschl RT; Turaga KK; Gamblin TC
    J Surg Oncol; 2013 May; 107(6):608-12. PubMed ID: 23386397
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined hepatocellular carcinoma and cholangiocarcinoma: clinical features, treatment modalities, and prognosis.
    Yin X; Zhang BH; Qiu SJ; Ren ZG; Zhou J; Chen XH; Zhou Y; Fan J
    Ann Surg Oncol; 2012 Sep; 19(9):2869-76. PubMed ID: 22451237
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of surgical treatment and poor prognostic factors for patients with intrahepatic cholangiocarcinoma: retrospective analysis of 60 patients.
    Yamashita Y; Taketomi A; Morita K; Fukuhara T; Ueda S; Sanefuji K; Iguchi T; Kayashima H; Sugimachi K; Maehara Y
    Anticancer Res; 2008; 28(4C):2353-9. PubMed ID: 18751418
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Survival analysis of intrahepatic cholangiocarcinoma after resection.
    Cho SY; Park SJ; Kim SH; Han SS; Kim YK; Lee KW; Lee SA; Hong EK; Lee WJ; Woo SM
    Ann Surg Oncol; 2010 Jul; 17(7):1823-30. PubMed ID: 20165987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resection of hilar cholangiocarcinoma: concomitant liver resection decreases hepatic recurrence.
    Ito F; Agni R; Rettammel RJ; Been MJ; Cho CS; Mahvi DM; Rikkers LF; Weber SM
    Ann Surg; 2008 Aug; 248(2):273-9. PubMed ID: 18650638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Local therapy reduces the risk of liver failure and improves survival in patients with intrahepatic cholangiocarcinoma: A comprehensive analysis of 362 consecutive patients.
    Yamashita S; Koay EJ; Passot G; Shroff R; Raghav KP; Conrad C; Chun YS; Aloia TA; Tao R; Kaseb A; Javle M; Crane CH; Vauthey JN
    Cancer; 2017 Apr; 123(8):1354-1362. PubMed ID: 27984655
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular factors associated with recurrence and survival following hepatectomy in patients with intrahepatic cholangiocarcinoma: a guide to adjuvant clinical trials.
    Schiffman SC; Nowacki MR; Spencer L; McMasters KM; Scoggins CR; Martin RC
    J Surg Oncol; 2014 Feb; 109(2):98-103. PubMed ID: 24122302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic factors of intrahepatic cholangiocarcinoma after hepatic resection: univariate and multivariate analysis.
    Hanazaki K; Kajikawa S; Shimozawa N; Shimada K; Hiraguri M; Koide N; Adachi W; Amano J
    Hepatogastroenterology; 2002; 49(44):311-6. PubMed ID: 11995440
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surgical management of intrahepatic cholangiocarcinoma--a population-based study.
    Tan JC; Coburn NG; Baxter NN; Kiss A; Law CH
    Ann Surg Oncol; 2008 Feb; 15(2):600-8. PubMed ID: 17987347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thermal ablation versus repeated hepatic resection for recurrent intrahepatic cholangiocarcinoma.
    Zhang SJ; Hu P; Wang N; Shen Q; Sun AX; Kuang M; Qian GJ
    Ann Surg Oncol; 2013 Oct; 20(11):3596-602. PubMed ID: 23715967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Two hundred forty consecutive portal vein embolizations before extended hepatectomy for biliary cancer: surgical outcome and long-term follow-up.
    Nagino M; Kamiya J; Nishio H; Ebata T; Arai T; Nimura Y
    Ann Surg; 2006 Mar; 243(3):364-72. PubMed ID: 16495702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intrahepatic cholangiocarcinoma: primary liver resection and aggressive multimodal treatment of recurrence significantly prolong survival.
    Ercolani G; Vetrone G; Grazi GL; Aramaki O; Cescon M; Ravaioli M; Serra C; Brandi G; Pinna AD
    Ann Surg; 2010 Jul; 252(1):107-14. PubMed ID: 20531002
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survival outcomes in resected extrahepatic cholangiocarcinoma: effect of adjuvant radiotherapy in a surveillance, epidemiology, and end results analysis.
    Vern-Gross TZ; Shivnani AT; Chen K; Lee CM; Tward JD; MacDonald OK; Crane CH; Talamonti MS; Munoz LL; Small W
    Int J Radiat Oncol Biol Phys; 2011 Sep; 81(1):189-98. PubMed ID: 20971573
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.